Reducing patient re-identification risk for laboratory results within research datasets.

J Am Med Inform Assoc

Department of Biomedical Informatics, School of Medicine, Vanderbilt University, Nashville, TN 37232-8340, USA.

Published: January 2013

AI Article Synopsis

  • Researchers aim to reduce the risk of re-identifying patients in biomedical databases while keeping clinical data useful for interpretation.
  • The study tested methods using the Vanderbilt TIME database, analyzing the uniqueness of lab results and applying perturbation models to protect data.
  • Results showed that while both models had similar re-identification rates, the expert-derived model better preserved clinical meaning compared to simple random adjustments, indicating a balanced approach to data sharing and privacy is possible.

Article Abstract

Objective: To try to lower patient re-identification risks for biomedical research databases containing laboratory test results while also minimizing changes in clinical data interpretation.

Materials And Methods: In our threat model, an attacker obtains 5-7 laboratory results from one patient and uses them as a search key to discover the corresponding record in a de-identified biomedical research database. To test our models, the existing Vanderbilt TIME database of 8.5 million Safe Harbor de-identified laboratory results from 61 280 patients was used. The uniqueness of unaltered laboratory results in the dataset was examined, and then two data perturbation models were applied-simple random offsets and an expert-derived clinical meaning-preserving model. A rank-based re-identification algorithm to mimic an attack was used. The re-identification risk and the retention of clinical meaning for each model's perturbed laboratory results were assessed.

Results: Differences in re-identification rates between the algorithms were small despite substantial divergence in altered clinical meaning. The expert algorithm maintained the clinical meaning of laboratory results better (affecting up to 4% of test results) than simple perturbation (affecting up to 26%).

Discussion And Conclusion: With growing impetus for sharing clinical data for research, and in view of healthcare-related federal privacy regulation, methods to mitigate risks of re-identification are important. A practical, expert-derived perturbation algorithm that demonstrated potential utility was developed. Similar approaches might enable administrators to select data protection scheme parameters that meet their preferences in the trade-off between the protection of privacy and the retention of clinical meaning of shared data.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555327PMC
http://dx.doi.org/10.1136/amiajnl-2012-001026DOI Listing

Publication Analysis

Top Keywords

clinical meaning
16
patient re-identification
8
re-identification risk
8
clinical data
8
retention clinical
8
laboratory
7
clinical
7
re-identification
6
data
5
reducing patient
4

Similar Publications

Article Synopsis
  • Laughter yoga shows benefits for mental health, life satisfaction, and stress coping skills.
  • A study involving 90 first-year nursing students examined its impact on stress perception and life meaning through pre-and post-tests after an intervention of eight laughter yoga sessions over four weeks.
  • Results indicate significant improvements in perceived stress and sense of life purpose among students who participated in laughter yoga.
View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint therapies have revolutionized cancer treatment but face challenges like low response rates and drug resistance, highlighting the need for a better understanding of the tumor microenvironment (TME).
  • Recent studies show that biomechanical forces within the TME significantly impact immune responses and tumor progression, indicating that manipulating these forces could enhance immune activation against tumors.
  • The review discusses key biomechanical mechanisms, the role of the extracellular matrix, and potential clinical applications, aiming to provide insights for discovering new therapeutic targets.
View Article and Find Full Text PDF

Unlabelled: Minimal residual disease (MRD) is the most important prognostic factor for B-cell acute lymphoblastic leukemia (B-ALL) however nearly 20-30% of patients relapsed even when they achieved negative MRD, how to identify these patients is less addressed. In this study, we aimed to reassess the prognostic significance of MRD and IKZF1 in adult B-ALL patients receiving pediatric chemotherapy regimens. In the PDT-ALL-2016 cohort (NCT03564470), adult B-ALL patients were treated with a pediatric-inspired regimen; patients were redefined as standard (MRD-negative and IKZF1wild-type), intermediate (MRD-positive or IKZF1 deletion), and high-risk (MRD-positive and IKZF1 deletion) groups by combining IKZF1 deletion status and MRD.

View Article and Find Full Text PDF

Background: The mentalization-based perspective of Borderline Personality Disorder (BPD) underscores fluctuating interpersonal functionality, believed to arise from suboptimal mentalization modes, including hyper- and hypomentalizing. The connection between ineffective mentalizing and specific BPD challenges remains ambiguous. Network theory offers a unique means to investigate the hypothesis that distinct yet interconnected mental challenges ('symptoms') construct 'disorders' through their continuous mutual interactions.

View Article and Find Full Text PDF

Background & Aims: A common genetic variant (rs738409) encoding isoleucine to methionine at position 148 in the PNPLA3 protein is a determinant of hepatic steatosis, inflammation, fibrosis, cirrhosis, and liver-related mortality. AZD2693 is a liver-targeted antisense oligonucleotide against PNPLA3 mRNA. We evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics in single ascending dose (SAD) and multiple ascending dose (MAD) studies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!